Question 1

What are the potential benefits of participating in this trial compared to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

Question 2

How will TCMCB07 be administered, and what should I expect during the injections?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of TCMCB07 and how do they compare to the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my weight and overall health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition changes during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

Question 6

Will participating in this trial affect my current chemotherapy schedule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy clinical trial (NCT06937177). Contact the study team or your healthcare provider for specific answers.

What this study is about